MFDS — authorised 31 December 1990
- Marketing authorisation holder: FERA PHARMS
- Status: likely_approved
🇰🇷 Dapiprazole Hydrochloride in South Korea
MFDS authorised Dapiprazole Hydrochloride on 31 December 1990
Marketing authorisation
Dapiprazole Hydrochloride in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in South Korea
Frequently asked questions
Is Dapiprazole Hydrochloride approved in South Korea?
Yes. MFDS authorised it on 31 December 1990.
Who is the marketing authorisation holder for Dapiprazole Hydrochloride in South Korea?
FERA PHARMS holds the South Korean marketing authorisation.